| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Carlos E Santos is Chief Financial Officer at LEGN. Carlos E Santos's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $306K at current prices.
The LEGN filings lean toward selling, a net 5,430 shares.
Carlos E Santos has 1 Form 4 filing on record in September 2026, as Chief Financial Officer at Legend Biotech (LEGN), 2026.
The 2 reported transactions were 1 stock award and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $50K.
The only open-market sale was 5,430 shares of LEGN at an average $9.14 on September 21, 2026, about $50K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | LEGN Legend Biotech Corporation | Chief Financial Officer | Sell | 5,430 | $9.14 | $49,630.20 | -27.6% | - | - |